Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial

Authors:

Abstract
No abstract available
Funding Information
  • EpicentRx, Inc.

This publication has 33 references indexed in Scilit: